![3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/daff6d9f-1965-4dab-86e7-94469d34f2b1/gr4.jpg)
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings
![Mayo Clinic Proceedings | Vol 94, Issue 4, Pages A1-A38, e51-e59, 561-738 (April 2019) | ScienceDirect.com by Elsevier Mayo Clinic Proceedings | Vol 94, Issue 4, Pages A1-A38, e51-e59, 561-738 (April 2019) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0025619619X00038-cov200h.gif)
Mayo Clinic Proceedings | Vol 94, Issue 4, Pages A1-A38, e51-e59, 561-738 (April 2019) | ScienceDirect.com by Elsevier
![Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma - Journal of Thoracic Oncology Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dc4593cc-7d28-420f-a718-4cfaaf9e2f91/gr1_lrg.jpg)
Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma - Journal of Thoracic Oncology
![3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Semantic Scholar 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/56e22c46bd26046a75ea8845b36a02281edfef21/8-Figure2-1.png)
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Semantic Scholar
![3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/12c3eeed-8c30-4cae-9394-d4ec2f55ca4b/gr4_lrg.jpg)
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings
![3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Semantic Scholar 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/56e22c46bd26046a75ea8845b36a02281edfef21/10-Figure4-1.png)
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk‐Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Semantic Scholar
![3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9cdae006-d462-4784-b374-05272c3c6862/gr1.jpg)
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Document - Gale OneFile: Health and Medicine
![Frontiers | Mitochondrial Medicine: Genetic Underpinnings and Disease Modeling Using Induced Pluripotent Stem Cell Technology Frontiers | Mitochondrial Medicine: Genetic Underpinnings and Disease Modeling Using Induced Pluripotent Stem Cell Technology](https://www.frontiersin.org/files/Articles/604581/fcvm-07-604581-HTML/image_m/fcvm-07-604581-g001.jpg)
Frontiers | Mitochondrial Medicine: Genetic Underpinnings and Disease Modeling Using Induced Pluripotent Stem Cell Technology
![3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ab866577-4156-4fce-b969-17b1611a6370/gr3_lrg.jpg)
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups - Mayo Clinic Proceedings
![3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Request PDF 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups | Request PDF](https://i1.rgstatic.net/ii/profile.image/572735950077952-1513562299105_Q64/Maura-Nicolosi.jpg)